Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity Article

sustainable development goals

publication date

  • January 1, 2016

webpage

published in

keywords

  • Bladder
  • Dasatinib
  • Neoadjuvant therapy
  • Protein kinase inhibitors
  • Src-family kinases
  • Translational medical research
  • Urothelial carcinoma

volume

  • 34

issue

  • 1